These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 9072007

  • 1. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 2. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J.
    Anticancer Res; 1998 Jun 01; 18(4A):2637-41. PubMed ID: 9703921
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, Kuribayashi T, Hirai K, Nabeshima K, Kotani T.
    Diagn Cytopathol; 2002 Jun 01; 26(6):366-72. PubMed ID: 12112826
    [Abstract] [Full Text] [Related]

  • 5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M, Kapila K, Verma K.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):376-80. PubMed ID: 17001889
    [Abstract] [Full Text] [Related]

  • 6. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW.
    Histopathology; 2004 Nov 01; 45(5):493-500. PubMed ID: 15500653
    [Abstract] [Full Text] [Related]

  • 7. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.
    Cancer Res; 1998 Jul 15; 58(14):3015-20. PubMed ID: 9679965
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC, el-Naggar AK, Lotan R.
    Am J Pathol; 1995 Sep 15; 147(3):815-22. PubMed ID: 7677193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.
    Pol J Pathol; 2003 Sep 15; 54(2):111-5. PubMed ID: 14575419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E.
    Hum Pathol; 2000 Apr 15; 31(4):428-33. PubMed ID: 10821488
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
    Tanaka T, Umeki K, Yamamoto I, Sugiyama S, Noguchi S, Ohtaki S.
    J Pathol; 1996 May 15; 179(1):89-94. PubMed ID: 8691351
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS.
    Histopathology; 2005 Oct 15; 47(4):391-401. PubMed ID: 16178894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.